<VariationArchive VariationID="1069245" VariationName="NM_003042.4(SLC6A1):c.1004dup (p.Phe336fs)" VariationType="Duplication" Accession="VCV001069245" Version="5" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2021-05-10" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1059568" VariationID="1069245">
      <GeneList>
        <Gene Symbol="SLC6A1" FullName="solute carrier family 6 member 1" GeneID="6529" HGNC_ID="HGNC:11042" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3p25.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="10992748" stop="11039247" display_start="10992748" display_stop="11039247" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="11034419" stop="11080934" display_start="11034419" display_stop="11080934" Strand="+" />
          </Location>
          <OMIM>137165</OMIM>
          <Haploinsufficiency last_evaluated="2019-09-25" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC6A1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-09-25" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC6A1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_003042.4(SLC6A1):c.1004dup (p.Phe336fs)</Name>
      <CanonicalSPDI>NC_000003.12:11026283:GG:GGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>3p25.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="11026283" stop="11026284" display_start="11026283" display_stop="11026284" variantLength="1" positionVCF="11026283" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="11067969" stop="11067970" display_start="11067969" display_stop="11067970" variantLength="1" positionVCF="11067969" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
      </Location>
      <ProteinChange>F158fs</ProteinChange>
      <ProteinChange>F216fs</ProteinChange>
      <ProteinChange>F336fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.11067971dup" Assembly="GRCh37">
            <Expression>NC_000003.11:g.11067971dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.11026285dup" Assembly="GRCh38">
            <Expression>NC_000003.12:g.11026285dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_053003.1" sequenceAccession="NG_053003" sequenceVersion="1" change="g.38557dup">
            <Expression>NG_053003.1:g.38557dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001348250.2" sequenceAccession="NM_001348250" sequenceVersion="2" change="c.1004dup">
            <Expression>NM_001348250.2:c.1004dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001335179.1" sequenceAccession="NP_001335179" sequenceVersion="1" change="p.Phe336fs">
            <Expression>NP_001335179.1:p.Phe336fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001348251.2" sequenceAccession="NM_001348251" sequenceVersion="2" change="c.644dup">
            <Expression>NM_001348251.2:c.644dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001335180.1" sequenceAccession="NP_001335180" sequenceVersion="1" change="p.Phe216fs">
            <Expression>NP_001335180.1:p.Phe216fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001348252.2" sequenceAccession="NM_001348252" sequenceVersion="2" change="c.470dup">
            <Expression>NM_001348252.2:c.470dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001335181.1" sequenceAccession="NP_001335181" sequenceVersion="1" change="p.Phe158fs">
            <Expression>NP_001335181.1:p.Phe158fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001348253.2" sequenceAccession="NM_001348253" sequenceVersion="2" change="c.470dup">
            <Expression>NM_001348253.2:c.470dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001335182.1" sequenceAccession="NP_001335182" sequenceVersion="1" change="p.Phe158fs">
            <Expression>NP_001335182.1:p.Phe158fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003042.4" sequenceAccession="NM_003042" sequenceVersion="4" change="c.1004dup" MANESelect="true">
            <Expression>NM_003042.4:c.1004dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003033.3" sequenceAccession="NP_003033" sequenceVersion="3" change="p.Phe336fs">
            <Expression>NP_003033.3:p.Phe336fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2124926277" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003042.4(SLC6A1):c.1004dup (p.Phe336fs) AND Myoclonic-atonic epilepsy" Accession="RCV003771236" Version="1">
        <ClassifiedConditionList TraitSetID="92306">
          <ClassifiedCondition DB="MedGen" ID="CN231318">Myoclonic-atonic epilepsy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-03-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-03-06" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-05-10" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">25865495</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="92306" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33535" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Myoclonic-atonic epilepsy</ElementValue>
                <XRef ID="MONDO:0014633" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MAE</ElementValue>
                <XRef Type="MIM" ID="616421" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16108" />
                <XRef ID="16108" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">36780407</ID>
                <ID Source="BookShelf">NBK589173</ID>
              </Citation>
              <XRef ID="1942" DB="Orphanet" />
              <XRef ID="CN231318" DB="MedGen" />
              <XRef ID="MONDO:0014633" DB="MONDO" />
              <XRef Type="MIM" ID="616421" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3104912" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="10121821|MedGen:C4085238" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001579307" DateUpdated="2024-02-28" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-03-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25865495</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in SLC6A1 are known to be pathogenic (PMID: 25865495). This variant has not been reported in the literature in individuals with SLC6A1-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Phe336Ilefs*20) in the SLC6A1 gene. It is expected to result in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC6A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.11067969_11067970insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4085238" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3104912" TraitType="Disease" MappingType="XRef" MappingValue="C4085238" MappingRef="MedGen">
        <MedGen CUI="CN231318" Name="Myoclonic-atonic epilepsy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

